Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity

被引:21
|
作者
Fournier, B
Hooper, DC
机构
[1] Harvard Univ, Div Infect Dis, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[2] Harvard Univ, Med Serv, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
关键词
D O I
10.1128/AAC.42.8.2109
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The grlA genes of Staphylococcus aureus ISP794 (wild type), MT5224c4 (grlA [Phe-80]), MT5224c2 (grlA [Pro-116]), and MT111 (grlA [Glu-116]) were cloned in pSK950, a shuttle vector, and introduced into S, aureus strains derived from strain RN4220. The mutations at position 116 of GrlA (Ala-->Pro or Glu) caused an increase in the level of fluoroquinolone resistance and a decrease in the level of coumarin susceptibility, whereas the mutation at position 80 (Ser-->Phe) caused only an increase in the level of fluoroquinolone resistance. In multicopy alleles, both types of mutations were codominant for fluoroquinolone resistance, and mutations at position 116 were also codominant for coumarin resistance.
引用
收藏
页码:2109 / 2112
页数:4
相关论文
共 50 条
  • [31] Molecular trends in emerging fluoroquinolone resistance in Argentina:: Detection of grlA and gyrA mutations in Staphylococcus aureus strains isolated from bacterial keratitis.
    Rossetti, S
    D'Alessandro, LP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S254 - S254
  • [32] OCCURRENCE OF QUINOLONE RESISTANCE IN STAPHYLOCOCCUS-AUREUS FROM NOSOCOMIAL INFECTION
    WITTE, W
    GRIMM, H
    EPIDEMIOLOGY AND INFECTION, 1992, 109 (03): : 413 - 421
  • [33] Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis
    Kowalczyk, Aleksandra
    Paneth, Agata
    Trojanowski, Damian
    Paneth, Piotr
    Zakrzewska-Czerwinska, Jolanta
    Staczek, Pawel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [34] Extended Spectrum of Quinolone Resistance, Even to a Potential Latter Third-Generation Agent, as a Result of a Minimum of Two GrlA and Two GyrA Alterations in Quinolone-Resistant Staphylococcus aureus
    Yoon, Eun-Jeong
    Lee, Chun-Yeong
    Shim, Mi-Ja
    Min, Yu-Hong
    Kwon, Ae-Ran
    Lee, Jongseo
    Choi, Eung-Chil
    CHEMOTHERAPY, 2010, 56 (02) : 153 - 157
  • [35] Dual targeting of DNA gyrase and topoisomerase IV:: Target interactions of heteroaryl isothiazolones in Staphylococcus aureus
    Cheng, Jijun
    Thanassi, Jane A.
    Thoma, Christy L.
    Bradbury, Barton J.
    Deshpande, Milind
    Pucci, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2445 - 2453
  • [36] Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics
    Alt, Silke
    Mitchenall, Lesley A.
    Maxwell, Anthony
    Heide, Lutz
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) : 2061 - 2069
  • [37] Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro
    Reinhardt, AK
    Bébéar, CM
    Kobisch, M
    Kempf, I
    Gautier-Bouchardon, AV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 590 - 593
  • [38] Structure of the topoisomerase IV from S. pneumoniae with a DNA target and quinolone drug
    Laponogov, Ivan
    Sohi, Maninder K.
    Veselkov, Dennis A.
    Pan, Xiao-Su
    Sawhney, Ritica
    Thompson, Andrew W.
    Fisher, L. Mark
    Sanderson, Mark R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C307 - C307
  • [39] Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines
    Werner, Malela M.
    Patel, Bhargav A.
    Talele, Tanaji T.
    Ashby, Charles R.
    Li, Zhiyu
    Zauhar, Randy J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (18) : 6125 - 6137
  • [40] Topoisomerase Mutations That Are Associated with High-Level Resistance to Earlier Fluoroquinolones in Staphylococcus aureus Have Less Effect on the Antibacterial Activity of Besifloxacin
    Sanfilippo, Christine M.
    Hesje, Christine K.
    Haas, Wolfgang
    Morris, Timothy W.
    CHEMOTHERAPY, 2011, 57 (05) : 363 - 371